Unlike the mechanism in liver cancer, where circPIAS1 inhibits ferroptosis through the miR-455-3p/NUPR1 axis, YBX3 directly targets SLC7A11 and destabilizes it through lysosomal degradation [24]. Here, YBX3 is linked to liver cancer.